As they work to consummate the merger between them first announced in June, Chicago-based Allscripts and Atlanta-based Eclipsys have announced investor meetings this month in their respective cities.
Allscripts-Misys Healthcare Solutions, Inc., reported that a record date and a special meeting date have been established for company stockholders to consider and vote upon a proposal to approve the issuance of shares of Allscripts common stock to stockholders of Eclipsys Corporation. The meeting is scheduled for August 13 at 9 a.m. local time at the offices of Sidley Austin LLP in Chicago.
Eclipsys, meanwhile, has announced that a similar meeting has been set for its shareholders to vote upon the proposed merger; it will take place on the same date at the company's Atlanta headquarters at 10 a.m. local time.The meetings do not signal the completion of the merger, which will occur after the shareholder votes are received and other necessary conditions to the merger are satisfied.(As often happens in such deals, at least one Eclipsys shareholder was unhappy about the merger, filing suit in June on behalf of investors and alleging breaches of fiduciary duty by the Eclipsys board for selling the company for too little.)
“The vote to approve our merger with Eclipsys is another important step forward towards completing this compelling strategic transaction,” said Allscripts CEO Glen Tullman. “Once approved, the merger will create a single company with the scale, breadth of applications and client relationships to transform healthcare by connecting hospitals, physician practices and post-acute organizations across the country.”
